MarketBeat.com

Israel-based ZIM Shipping shares have risen 36% year-to-date (YTD) despite the Red Sea disruptions from Houthi attacks on shipping vessels. Spot freight rates from China to some European destinations...

Advanced Micro Devices is moving to new highs on a string of analyst updates that see this market setting a record in 2024. Forecasts for Q4 2023 and 2024 are low, given the demand for AI chips, and...

Salesforce shares are continuing to gain this month after a triple-digit percentage gain last year. Analysts have been upgrading their ratings on the stock and boosting their price targets. For...

Mobileye issued disappointing revenue guidance, citing excess inventory and customer stockpiling. Microchip Technology cited auto manufacturing slowdowns as a factor in its revenue declines. Intel...

The SIA data shows semiconductor sales returned to growth in Q4 2023. The outlook in 2024 is for double-digit revenue growth led by AI. These are the top stocks in the best position to capture gains...

Shipping stocks are down the week of January 8 amid rumors the Red Sea conflict was resolved, but Maersk and Hapag-Lloyd denied the reports. Shipping companies may see higher revenue as price in...

AstraZeneca gained 8.95% in the past month, fueled by optimism about its 2024 earnings outlook. Rising sales of cancer and diabetes drugs are key contributors to AstraZeneca's positive...

Envista Holdings insiders are buying, but investors should wait for the next decline before buying in. Curtiss-Wright is in a sustained uptrend with growth in the forecast and analysts supporting the...

Even after the early-in-the-month pullback, the S&P 500 is trading less than 1% below its December 28 high. Stocks like Nvidia and Eli Lilly are good indicators that investors still have...

Apple has lagged the broader market since the middle of last month. Historically, its shares have always bounced back once the technical indicators pointed to them being oversold. Last Friday, we saw...

Bluebird Bio has three FDA-approved gene therapy treatments that are planning to commercialize after its $150 million secondary offering of common shares priced at $1.50 per share. Bluebird bio's...

The U.S. IPO market kicks off on January 11 with Smith Douglas Homes, which expects a valuation of $1.08 billion. Companies that may go public this year include Reddit, Databricks, Stripe, Turo, Shein...

Chipotle Mexican Grill hit a top at the end of 2023, but new highs are in the forecast. The year's first five analysts' revisions have this stock trading at an all-time high. The bar for Q4 results is...

The U.S. Securities and Exchange Commission (SEC) is expected to decide on approving, denying, or pausing spot bitcoin ETFs by Jan. 10, 2024. Coinbase is the largest U.S. cryptocurrency exchange and...

Intel's 2023 rally still has legs, and 2024 looks just as bright. Several key tailwinds are in place, which should support a push for all-time highs. Even with recent gains, Intel's valuation remains...

By the end of 2023, the Magnificent 7 tech stocks accounted for about 33% of S&P 500 market cap. Analysts see reasons that many of these stocks can build on that outperformance in 2024. The...